MYND Life Sciences Inc. filed its Annual on Apr 28, 2023 for the period ending Oct 31, 2022. In this report its auditor, Meyers Norris Penny LLP - MNP LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | 0.00% | -25.00% | -25.00% |
1st Jan change | Capi. | |
---|---|---|
-25.00% | 1.05M | |
+5.53% | 111B | |
+11.87% | 106B | |
-12.53% | 22.24B | |
+0.17% | 21.25B | |
-4.92% | 18.97B | |
-35.21% | 18.52B | |
-11.13% | 16.81B | |
+37.76% | 12.54B | |
-25.05% | 8.09B |
- Stock Market
- Equities
- MYND Stock
- News MYND Life Sciences Inc.
- MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt